These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12542004)

  • 1. The HIV/AIDS vaccine research effort: an update.
    Beyrer C
    Hopkins HIV Rep; 2003 Jan; 15(1):6-7. PubMed ID: 12542004
    [No Abstract]   [Full Text] [Related]  

  • 2. Chitin Micro-Particles (CMP): a useful adjuvant for inducing viral specific immunity when delivered intranasally with an HIV-DNA vaccine.
    Hamajima K; Kojima Y; Matsui K; Toda Y; Jounai N; Ozaki T; Xin KQ; Strong P; Okuda K
    Viral Immunol; 2003; 16(4):541-7. PubMed ID: 14733740
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunization. Update: search for an AIDS vaccine.
    Bende S; Johnston MI
    AIDS Read; 2000 Sep; 10(9):526-32, 534-8. PubMed ID: 11019448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-DNA vaccination following transfer of a large number of activated T cells enhances immunoresponses against HIV-1.
    Hamajima K; Xin KQ; Fukushima J; Yang J; Honsho A; Nakazawa M; Yanoma S; Okuda K
    Viral Immunol; 2000; 13(1):3-8. PubMed ID: 10733163
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel adjuvants and delivery systems for HIV vaccines.
    O'Hagan DT; Lavelle E
    AIDS; 2002; 16 Suppl 4():S115-24. PubMed ID: 12699008
    [No Abstract]   [Full Text] [Related]  

  • 6. One step forwards, one step back.
    Lifson JD; Martin MA
    Nature; 2002 Jan; 415(6869):272-3. PubMed ID: 11796990
    [No Abstract]   [Full Text] [Related]  

  • 7. ADVAX, new DNA vaccine in human trial; HIV-negative volunteers needed in New York City or Rochester, NY areas.
    James JS
    AIDS Treat News; 2004 Jun; (402):8. PubMed ID: 15272461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New oral DNA vaccine funded for trials.
    James JS
    AIDS Treat News; 2000 Jun; (344):3. PubMed ID: 12170972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.
    Gudmundsdotter L; Wahren B; Haller BK; Boberg A; Edbäck U; Bernasconi D; Buttò S; Gaines H; Imami N; Gotch F; Lori F; Lisziewicz J; Sandström E; Hejdeman B
    Vaccine; 2011 Jul; 29(33):5558-66. PubMed ID: 21300092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India.
    Kumar S; Aggarwal P; Vajpayee M; Pandey RM; Seth P
    Vaccine; 2006 Mar; 24(14):2585-93. PubMed ID: 16480792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Working towards an HIV/AIDS vaccine.
    Robinson HL
    Hum Vaccin; 2009 Jul; 5(7):436-8. PubMed ID: 19662687
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of DNA vaccine and adenovirus vector by cutaneous administration induced strong HIV-specific cellular immune responses in mice.
    Takakura M; Okuda K; Matsuda T; Takeshita F; Takakura H; Ikezawa Z; Xin KQ
    Vaccine; 2005 Jan; 23(7):847-8. PubMed ID: 15603883
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.
    Rosa DS; Ribeiro SP; Fonseca SG; Almeida RR; Santana VC; Apostólico Jde S; Kalil J; Cunha-Neto E
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1077-88. PubMed ID: 26149745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
    Shata MT; Hone DM
    J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA and other technologies for HIV vaccines.
    Bowers M
    BETA; 1998 Apr; ():9-12, 28. PubMed ID: 11365275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A novel immunization strategy to induce strong humoral responses against HIV-1 using combined DNA, recombinant vaccinia virus and protein vaccines].
    Liu C; Wang SH; Ren L; Hao YL; Zhang QC; Liu Y
    Bing Du Xue Bao; 2014 Nov; 30(6):645-51. PubMed ID: 25868279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
    Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation.
    Yin J; Dai A; Lecureux J; Arango T; Kutzler MA; Yan J; Lewis MG; Khan A; Sardesai NY; Montefiore D; Ruprecht R; Weiner DB; Boyer JD
    Vaccine; 2011 Sep; 29(39):6763-70. PubMed ID: 21195801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 vaccine clinical trials: the Brazilian experience.
    Ersching J; Pinto AR
    Rev Med Virol; 2009 Sep; 19(5):301-11. PubMed ID: 19650156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.
    Hirao LA; Wu L; Khan AS; Satishchandran A; Draghia-Akli R; Weiner DB
    Vaccine; 2008 Jan; 26(3):440-8. PubMed ID: 18082294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.